Evidence brief · Supplement
Centrophenoxine for Cognition (elderly)
Evidence grade D — Dated
- Overall grade
- Grade D
- Last revised
- 1
- graded outcome
- 0
- references listed
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
1 at grade D — 1 graded row
What is known
Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.
- Cognition (elderly)Evidence grade D
Dated
Triviallow
What is uncertain
Read off the same rows as above. Nothing here is added that the entry does not itself record.
- Thin evidence: Cognition (elderly) (grade D).
The evidence in words
The verdict
For cognition (elderly), Centrophenoxine earns evidence grade D (trivial effect, low consistency) — the evidence does not support the claim. Dated
How it might work
It raises acetylcholine and helps clear lipofuscin (an aging pigment) in models.
How to use it
Safety & cautions
Generally tolerated.
Bottom line
An aging-brain compound with dated, weak evidence. Not established for healthy cognition.
Goes with
- CentrophenoxineRead the full Centrophenoxine monographEvidence grade D
Related reading
Entries that share this one's tags or conditions.
- Centrophenoxine: side effects, safety & interactionsGenerally tolerated.Evidence grade D
- DMAEA choline-adjacent compound for focus and skin with weak, mixed evidence.Evidence grade D
- DMAE for Cognition / moodEvidence grade D — MixedEvidence grade D
- AniracetamA fat-soluble racetam with an anxiety-and-mood reputation and mostly preclinical human backing.Evidence grade D
Sources
This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.
Last revised . A grade is this entry's reading of the evidence, not medical advice.